欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > AMD-070

商品分类

浏览历史

Y39077

AMD-070

源叶(MedMol) ≥99%
  • 英文名:
  • (S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
  • 别名:
  • AMD11070, AMD 11070, AMD-11070, AMD070, AMD 070, AMD-070, X4P-001, X49001, X4P 001, Mavorixafor
  • CAS号:
  • 558447-26-0
  • 分子式:
  • C21H27N5
  • 分子量:
  • 349.48
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) Y39077-5mg ≥99% ¥1000.00元 预计交期:3-5天 0 0 0 EA 加入购物车
源叶(MedMol) Y39077-10mg ≥99% ¥1500.00元 预计交期:3-5天 0 0 0 EA 加入购物车
源叶(MedMol) Y39077-25mg ≥99% ¥2600.00元 预计交期:3-5天 0 0 0 EA 加入购物车
源叶(MedMol) Y39077-50mg ≥99% ¥4600.00元 预计交期:3-5天 0 0 0 EA 加入购物车
源叶(MedMol) Y39077-100mg ≥99% ¥6400.00元 预计交期:3-5天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: Mavorixafor (AMD-070) is a potent, selective and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 and 9 nM, respectively
  • 靶点: 125I-SDF-CXCR4:13 nM (IC50);HIV-1 (NL4.3 strain):1 nM (IC50, in MT-4 cells);HIV-1 (NL4.3 strain):9 nM (IC50, in PBMCs);HIV-1 (NL4.3 strain):3 nM (IC90, in MT-4 cells);HIV-1 (NL4.3 strain):26 nM (IC90, in PBMCs)
  • 体外研究: Mavorixafor (AMD-070) is a potent and orally available CXCR4 antagonist, with an IC50 value of 13 nM against CXCR4 125I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC50 of 1 and 9 nM, respectively. Mavorixafor (AMD-070) shows no effect on other chemokine receptors (CCR1, CCR2b, CCR4, CCR5, CXCR1, and CXCR2). Mavorixafor (AMD-070) (6.6 µM) significantly suppresses the anchorage-dependent growth, the migration and matrigel invasion of the B88-SDF-1 cells
  • 体内研究: Mavorixafor (AMD-070) (2 mg/kg, p.o.) significantly reduces the number of metastatic lung nodules in mice, and lowers the expression of human Alu DNA in mice, without body weight loss
  • 参考文献:
    1. Skerlj RT, et al. Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication. J Med Chem. 2010 Apr 22;53(8):3376-88. 2. Chow LN, et al. Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice. PLoS One. 2016 Mar 21;11(3):e0151765. 3. Uchida D, et al. Effect of a novel orally bioavailable CXCR4 inhibitor, AMD070, on the metastasis of oral cancer cells. Oncol Rep. 2018 Jul;40(1):303-308.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.861 ml 14.307 ml 28.614 ml
    5 mM 0.572 ml 2.861 ml 5.723 ml
    10 mM 0.286 ml 1.431 ml 2.861 ml
    50 mM 0.057 ml 0.286 ml 0.572 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。